Patent · US Expired

Dibenzb,e!oxepin derivatives and pharmaceutical agents which contain them

US5696155A · kind A · utility

0Cited by

0References

7Claims

0Family size

Assignee

Boehringer Mannheim BmbH · DE

Inventors

Walter-Gunar Friebe · Mannheim, DE
Werner Scheuer · Penzberg, DE
Ulrich Tibes · Starnberg, DE

Key dates

Filing date	Sep 10, 1996
Grant date	Dec 9, 1997
Priority date	—
Expiry date	Sep 10, 2016

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D313/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Compounds of formula I ##STR1## in which Q denotes hydrogen, a hydroxy group or a C.sub.1 to C.sub.8 alkoxy group which can be substituted if desired, by carboxyl or C.sub.1 to C.sub.6 alkoxycarbonyl and either PA1 Y and Z together form a group ##STR2## and X represents hydrogen, C.sub.1 to C.sub.6 alkyl or C.sub.2 to C.sub.6 alkenyl or PA1 Y and X together form a group ##STR3## or an alkylene residue of 2-4 carbon atoms and Z represents hydrogen, C.sub.1 to C.sub.6 alkyl or C.sub.1 to C.sub.6 alkanoyl, where PA1 R denotes hydrogen or a C.sub.1 to C.sub.6 alkyl residue as well as physiologically tolerated salts thereof, processes for their production and pharmaceutical agents containing these compounds for the treatment of inflammatory diseases and allergic diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.